Perampanel for the treatment of Asian people with epilepsy: Real-world evidence from the PERMIT extension study
This post-hoc analysis of the PERMIT Extension study compared the effectiveness and safety/tolerability of perampanel (PER) between Asian and non-Asian participants. Retention rates, adverse events (AEs), seizure frequency, responder rate (≥50% seizure frequency reduction), and seizure freedom rate (no seizures since at least the prior visit) were assessed. Retention was assessed after 3, 6 and 12 months. Effectiveness assessments were evaluated at 3, 6 and 12 months and the last visit by seizure type (total, focal and generalised).
https://www.jns-journal.com/ar....ticle/S0022-510X(24)
Discover the world at Altruu, The Discovery Engine